Expertise in
12
conditions

Klaus L. Mohnike

Leipziger Street 44, 
Magdeburg, ST, DE 
Expertise in
12
conditions
Leipziger Street 44, 
Magdeburg, ST, DE 

Overview

Klaus Mohnike practices practicing medicine in Magdeburg, Germany.

Mr. Mohnike is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Achondroplasia, Congenital Hyperinsulinism, Low Blood Sugar, Hormone Replacement Therapy (HRT), and Pancreatectomy.

He is actively involved in clinical research, co-authoring 101 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Leipziger Street 44, Magdeburg, ST 39120, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2, Multiple Ascending Dose, Open-label, Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
A Phase 2, Multiple Ascending Dose, Open-label, Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2026
Intervention Type: Drug
Study Drug: HM15136
Study Phase: Phase 2
A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
Enrollment Status: Completed
Publish Date: July 20, 2025
Intervention Type: Drug
Study Drugs: MOD-4023, Somatropin
Study Phase: Phase 3
An Open-Label Multiple-Dose Study of RZ358 in Patients With Congenital Hyperinsulinism
An Open-Label Multiple-Dose Study of RZ358 in Patients With Congenital Hyperinsulinism
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Drug
Study Drug: RZ358
Study Phase: Phase 2
A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
Enrollment Status: Completed
Publish Date: August 29, 2024
Intervention Type: Drug, Biological
Study Phase: Phase 3
View 3 Less Clinical Trials

100 Total Publications

Development and pilot testing of the quality of life of parents of children with achondroplasia questionnaire.
Development and pilot testing of the quality of life of parents of children with achondroplasia questionnaire.
Journal: Journal of patient-reported outcomes
Published: April 08, 2026

Frequently Asked Questions about Klaus L. Mohnike

Is Klaus L. Mohnike a top-rated expert for Achondroplasia?

MediFind is an objective health platform that identifies experts based on real-world data. Klaus L. Mohnike is classified as an Elite expert for Achondroplasia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Klaus L. Mohnike participate in research or clinical trials?

Yes. Klaus L. Mohnike has published 100 articles and abstracts on conditions like Achondroplasia. You can view a list of Klaus L. Mohnike's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mohnike's expertise for a condition
ConditionClose
View All 34 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile